nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclopentolate—BCHE—Alzheimer's disease	0.421	1	CbGaD
Cyclopentolate—BCHE—Rivastigmine—Alzheimer's disease	0.317	0.66	CbGbCtD
Cyclopentolate—BCHE—Galantamine—Alzheimer's disease	0.163	0.34	CbGbCtD
Cyclopentolate—Hyperpyrexia—Rivastigmine—Alzheimer's disease	0.00368	0.0536	CcSEcCtD
Cyclopentolate—Paralysis—Memantine—Alzheimer's disease	0.00202	0.0294	CcSEcCtD
Cyclopentolate—Vasodilation—Donepezil—Alzheimer's disease	0.00176	0.0256	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Donepezil—Alzheimer's disease	0.00176	0.0256	CcSEcCtD
Cyclopentolate—Hyperkinesia—Galantamine—Alzheimer's disease	0.00174	0.0253	CcSEcCtD
Cyclopentolate—Gastroenteritis—Galantamine—Alzheimer's disease	0.00163	0.0238	CcSEcCtD
Cyclopentolate—Coordination abnormal—Memantine—Alzheimer's disease	0.00143	0.0208	CcSEcCtD
Cyclopentolate—Coordination abnormal—Rivastigmine—Alzheimer's disease	0.0014	0.0203	CcSEcCtD
Cyclopentolate—Urinary retention—Galantamine—Alzheimer's disease	0.00138	0.02	CcSEcCtD
Cyclopentolate—Ataxia—Galantamine—Alzheimer's disease	0.00136	0.0198	CcSEcCtD
Cyclopentolate—Coma—Memantine—Alzheimer's disease	0.00128	0.0187	CcSEcCtD
Cyclopentolate—Gastroenteritis—Donepezil—Alzheimer's disease	0.00126	0.0184	CcSEcCtD
Cyclopentolate—Coma—Rivastigmine—Alzheimer's disease	0.00125	0.0182	CcSEcCtD
Cyclopentolate—Hyperkinesia—Memantine—Alzheimer's disease	0.00122	0.0178	CcSEcCtD
Cyclopentolate—Hyperkinesia—Rivastigmine—Alzheimer's disease	0.0012	0.0174	CcSEcCtD
Cyclopentolate—Gastroenteritis—Memantine—Alzheimer's disease	0.00115	0.0167	CcSEcCtD
Cyclopentolate—Disorientation—Memantine—Alzheimer's disease	0.00114	0.0166	CcSEcCtD
Cyclopentolate—Gastroenteritis—Rivastigmine—Alzheimer's disease	0.00112	0.0164	CcSEcCtD
Cyclopentolate—Psychotic disorder—Donepezil—Alzheimer's disease	0.00109	0.0159	CcSEcCtD
Cyclopentolate—Urinary retention—Donepezil—Alzheimer's disease	0.00107	0.0155	CcSEcCtD
Cyclopentolate—Ataxia—Donepezil—Alzheimer's disease	0.00105	0.0153	CcSEcCtD
Cyclopentolate—Hallucination—Galantamine—Alzheimer's disease	0.000995	0.0145	CcSEcCtD
Cyclopentolate—Psychotic disorder—Memantine—Alzheimer's disease	0.000994	0.0145	CcSEcCtD
Cyclopentolate—Abdominal distension—Donepezil—Alzheimer's disease	0.000975	0.0142	CcSEcCtD
Cyclopentolate—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.000972	0.0142	CcSEcCtD
Cyclopentolate—Urinary retention—Memantine—Alzheimer's disease	0.000968	0.0141	CcSEcCtD
Cyclopentolate—Ataxia—Memantine—Alzheimer's disease	0.000957	0.0139	CcSEcCtD
Cyclopentolate—Urinary retention—Rivastigmine—Alzheimer's disease	0.000947	0.0138	CcSEcCtD
Cyclopentolate—Ataxia—Rivastigmine—Alzheimer's disease	0.000936	0.0136	CcSEcCtD
Cyclopentolate—Flushing—Galantamine—Alzheimer's disease	0.000928	0.0135	CcSEcCtD
Cyclopentolate—Conjunctivitis—Donepezil—Alzheimer's disease	0.00084	0.0122	CcSEcCtD
Cyclopentolate—Vision blurred—Galantamine—Alzheimer's disease	0.000821	0.012	CcSEcCtD
Cyclopentolate—Tremor—Galantamine—Alzheimer's disease	0.000816	0.0119	CcSEcCtD
Cyclopentolate—Agitation—Galantamine—Alzheimer's disease	0.0008	0.0117	CcSEcCtD
Cyclopentolate—Vertigo—Galantamine—Alzheimer's disease	0.000782	0.0114	CcSEcCtD
Cyclopentolate—Hallucination—Donepezil—Alzheimer's disease	0.000771	0.0112	CcSEcCtD
Cyclopentolate—Drowsiness—Rivastigmine—Alzheimer's disease	0.000767	0.0112	CcSEcCtD
Cyclopentolate—Conjunctivitis—Memantine—Alzheimer's disease	0.000762	0.0111	CcSEcCtD
Cyclopentolate—Desvenlafaxine—SLC6A4—Alzheimer's disease	0.000756	0.199	CrCbGaD
Cyclopentolate—Convulsion—Galantamine—Alzheimer's disease	0.000755	0.011	CcSEcCtD
Cyclopentolate—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000746	0.0109	CcSEcCtD
Cyclopentolate—Dry mouth—Galantamine—Alzheimer's disease	0.000725	0.0106	CcSEcCtD
Cyclopentolate—Hallucination—Memantine—Alzheimer's disease	0.0007	0.0102	CcSEcCtD
Cyclopentolate—Tachycardia—Galantamine—Alzheimer's disease	0.000694	0.0101	CcSEcCtD
Cyclopentolate—Hallucination—Rivastigmine—Alzheimer's disease	0.000685	0.00998	CcSEcCtD
Cyclopentolate—Flushing—Memantine—Alzheimer's disease	0.000653	0.00951	CcSEcCtD
Cyclopentolate—Flushing—Rivastigmine—Alzheimer's disease	0.000639	0.00931	CcSEcCtD
Cyclopentolate—Vision blurred—Donepezil—Alzheimer's disease	0.000636	0.00926	CcSEcCtD
Cyclopentolate—Tremor—Donepezil—Alzheimer's disease	0.000632	0.00921	CcSEcCtD
Cyclopentolate—Somnolence—Galantamine—Alzheimer's disease	0.000632	0.0092	CcSEcCtD
Cyclopentolate—Agitation—Donepezil—Alzheimer's disease	0.00062	0.00903	CcSEcCtD
Cyclopentolate—Vertigo—Donepezil—Alzheimer's disease	0.000606	0.00883	CcSEcCtD
Cyclopentolate—Convulsion—Donepezil—Alzheimer's disease	0.000585	0.00851	CcSEcCtD
Cyclopentolate—Vision blurred—Memantine—Alzheimer's disease	0.000578	0.00841	CcSEcCtD
Cyclopentolate—Tremor—Memantine—Alzheimer's disease	0.000574	0.00836	CcSEcCtD
Cyclopentolate—Vision blurred—Rivastigmine—Alzheimer's disease	0.000565	0.00823	CcSEcCtD
Cyclopentolate—Agitation—Memantine—Alzheimer's disease	0.000563	0.0082	CcSEcCtD
Cyclopentolate—Dry mouth—Donepezil—Alzheimer's disease	0.000562	0.00818	CcSEcCtD
Cyclopentolate—Tremor—Rivastigmine—Alzheimer's disease	0.000562	0.00818	CcSEcCtD
Cyclopentolate—Pethidine—GRIN2B—Alzheimer's disease	0.000554	0.145	CrCbGaD
Cyclopentolate—Agitation—Rivastigmine—Alzheimer's disease	0.000551	0.00802	CcSEcCtD
Cyclopentolate—Vertigo—Memantine—Alzheimer's disease	0.000551	0.00802	CcSEcCtD
Cyclopentolate—Vertigo—Rivastigmine—Alzheimer's disease	0.000539	0.00784	CcSEcCtD
Cyclopentolate—Convulsion—Memantine—Alzheimer's disease	0.000531	0.00773	CcSEcCtD
Cyclopentolate—Convulsion—Rivastigmine—Alzheimer's disease	0.000519	0.00756	CcSEcCtD
Cyclopentolate—Dry mouth—Memantine—Alzheimer's disease	0.00051	0.00743	CcSEcCtD
Cyclopentolate—Dry mouth—Rivastigmine—Alzheimer's disease	0.000499	0.00727	CcSEcCtD
Cyclopentolate—Somnolence—Donepezil—Alzheimer's disease	0.00049	0.00713	CcSEcCtD
Cyclopentolate—Tachycardia—Memantine—Alzheimer's disease	0.000488	0.00711	CcSEcCtD
Cyclopentolate—Tachycardia—Rivastigmine—Alzheimer's disease	0.000478	0.00695	CcSEcCtD
Cyclopentolate—Rash—Galantamine—Alzheimer's disease	0.000448	0.00653	CcSEcCtD
Cyclopentolate—Dermatitis—Galantamine—Alzheimer's disease	0.000448	0.00652	CcSEcCtD
Cyclopentolate—Somnolence—Memantine—Alzheimer's disease	0.000445	0.00647	CcSEcCtD
Cyclopentolate—Somnolence—Rivastigmine—Alzheimer's disease	0.000435	0.00633	CcSEcCtD
Cyclopentolate—Pruritus—Donepezil—Alzheimer's disease	0.00039	0.00567	CcSEcCtD
Cyclopentolate—Dexmethylphenidate—SLC6A4—Alzheimer's disease	0.000387	0.102	CrCbGaD
Cyclopentolate—Methylphenidate—SLC6A4—Alzheimer's disease	0.000387	0.102	CrCbGaD
Cyclopentolate—Venlafaxine—SLC6A4—Alzheimer's disease	0.000382	0.1	CrCbGaD
Cyclopentolate—Pruritus—Memantine—Alzheimer's disease	0.000354	0.00515	CcSEcCtD
Cyclopentolate—Rash—Donepezil—Alzheimer's disease	0.000347	0.00506	CcSEcCtD
Cyclopentolate—Dermatitis—Donepezil—Alzheimer's disease	0.000347	0.00505	CcSEcCtD
Cyclopentolate—Pruritus—Rivastigmine—Alzheimer's disease	0.000346	0.00504	CcSEcCtD
Cyclopentolate—Rash—Memantine—Alzheimer's disease	0.000315	0.00459	CcSEcCtD
Cyclopentolate—Dermatitis—Memantine—Alzheimer's disease	0.000315	0.00459	CcSEcCtD
Cyclopentolate—Rash—Rivastigmine—Alzheimer's disease	0.000308	0.00449	CcSEcCtD
Cyclopentolate—Dermatitis—Rivastigmine—Alzheimer's disease	0.000308	0.00449	CcSEcCtD
Cyclopentolate—Dexmethylphenidate—CYP2D6—Alzheimer's disease	0.000272	0.0714	CrCbGaD
Cyclopentolate—Methylphenidate—CYP2D6—Alzheimer's disease	0.000272	0.0714	CrCbGaD
Cyclopentolate—Venlafaxine—CYP2D6—Alzheimer's disease	0.000269	0.0706	CrCbGaD
Cyclopentolate—Pethidine—SLC6A4—Alzheimer's disease	0.000196	0.0514	CrCbGaD
Cyclopentolate—Pethidine—CYP2D6—Alzheimer's disease	0.000138	0.0361	CrCbGaD
Cyclopentolate—Diphenhydramine—PTGS1—Alzheimer's disease	0.000117	0.0306	CrCbGaD
Cyclopentolate—Diphenhydramine—CYP2D6—Alzheimer's disease	7.93e-05	0.0208	CrCbGaD
Cyclopentolate—CHRM1—forebrain—Alzheimer's disease	5.02e-05	0.108	CbGeAlD
Cyclopentolate—CHRM1—telencephalon—Alzheimer's disease	4.62e-05	0.0989	CbGeAlD
Cyclopentolate—CHRM3—forebrain—Alzheimer's disease	4.5e-05	0.0962	CbGeAlD
Cyclopentolate—CHRM3—telencephalon—Alzheimer's disease	4.13e-05	0.0885	CbGeAlD
Cyclopentolate—BCHE—forebrain—Alzheimer's disease	3.67e-05	0.0785	CbGeAlD
Cyclopentolate—BCHE—telencephalon—Alzheimer's disease	3.37e-05	0.0722	CbGeAlD
Cyclopentolate—CHRM3—Signaling by GPCR—GAL—Alzheimer's disease	2.79e-05	0.0011	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.76e-05	0.00109	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TTR—Alzheimer's disease	2.73e-05	0.00108	CbGpPWpGaD
Cyclopentolate—CHRM1—nervous system—Alzheimer's disease	2.73e-05	0.0584	CbGeAlD
Cyclopentolate—CHRM3—Signaling Pathways—TTR—Alzheimer's disease	2.72e-05	0.00107	CbGpPWpGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	2.72e-05	0.00107	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	2.71e-05	0.00107	CbGpPWpGaD
Cyclopentolate—CHRM1—central nervous system—Alzheimer's disease	2.63e-05	0.0562	CbGeAlD
Cyclopentolate—BCHE—Metabolism of proteins—IGF2—Alzheimer's disease	2.57e-05	0.00101	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—TPI1—Alzheimer's disease	2.54e-05	0.001	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CHAT—Alzheimer's disease	2.54e-05	0.001	CbGpPWpGaD
Cyclopentolate—CHRM3—nervous system—Alzheimer's disease	2.44e-05	0.0522	CbGeAlD
Cyclopentolate—BCHE—Metabolism—MAOB—Alzheimer's disease	2.43e-05	0.000958	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—NPY—Alzheimer's disease	2.42e-05	0.000955	CbGpPWpGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	2.42e-05	0.000954	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—NPY—Alzheimer's disease	2.42e-05	0.000952	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	2.41e-05	0.000951	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—CCR5—Alzheimer's disease	2.41e-05	0.00095	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—IAPP—Alzheimer's disease	2.41e-05	0.000949	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—CCR5—Alzheimer's disease	2.4e-05	0.000947	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—IAPP—Alzheimer's disease	2.4e-05	0.000946	CbGpPWpGaD
Cyclopentolate—CHRM1—Circadian rythm related genes—MAPK8—Alzheimer's disease	2.4e-05	0.000946	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PYY—Alzheimer's disease	2.39e-05	0.000941	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PYY—Alzheimer's disease	2.38e-05	0.000938	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—HTR2A—Alzheimer's disease	2.36e-05	0.00093	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—HTR2A—Alzheimer's disease	2.35e-05	0.000927	CbGpPWpGaD
Cyclopentolate—CHRM3—central nervous system—Alzheimer's disease	2.35e-05	0.0503	CbGeAlD
Cyclopentolate—BCHE—Metabolism—GAPDH—Alzheimer's disease	2.34e-05	0.000923	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—CRH—Alzheimer's disease	2.34e-05	0.000921	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—CRH—Alzheimer's disease	2.33e-05	0.000918	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.31e-05	0.000912	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.29e-05	0.000904	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—A2M—Alzheimer's disease	2.26e-05	0.000891	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—NPS—Alzheimer's disease	2.22e-05	0.000873	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—NPS—Alzheimer's disease	2.21e-05	0.000871	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—NPY—Alzheimer's disease	2.2e-05	0.000867	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—NPY—Alzheimer's disease	2.19e-05	0.000864	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—IAPP—Alzheimer's disease	2.19e-05	0.000862	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—IAPP—Alzheimer's disease	2.18e-05	0.000859	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CRH—Alzheimer's disease	2.12e-05	0.000837	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CRH—Alzheimer's disease	2.12e-05	0.000834	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—GAB2—Alzheimer's disease	2.11e-05	0.000833	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—SST—Alzheimer's disease	2.11e-05	0.000833	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—GAB2—Alzheimer's disease	2.11e-05	0.000831	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—SST—Alzheimer's disease	2.11e-05	0.000831	CbGpPWpGaD
Cyclopentolate—CHRM1—brain—Alzheimer's disease	2.08e-05	0.0446	CbGeAlD
Cyclopentolate—CHRM1—Signaling Pathways—CDK5—Alzheimer's disease	2.07e-05	0.000816	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—F2—Alzheimer's disease	2.07e-05	0.000815	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CDK5—Alzheimer's disease	2.06e-05	0.000813	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—F2—Alzheimer's disease	2.06e-05	0.000813	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—APP—Alzheimer's disease	2.06e-05	0.000812	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—APP—Alzheimer's disease	2.05e-05	0.000809	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.02e-05	0.000795	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—NPS—Alzheimer's disease	2.01e-05	0.000793	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—NPS—Alzheimer's disease	2.01e-05	0.000791	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PPP3CA—Alzheimer's disease	2e-05	0.000789	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of proteins—LEP—Alzheimer's disease	2e-05	0.000788	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PPP3CA—Alzheimer's disease	2e-05	0.000787	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HTR6—Alzheimer's disease	1.99e-05	0.000785	CbGpPWpGaD
Cyclopentolate—BCHE—nervous system—Alzheimer's disease	1.99e-05	0.0426	CbGeAlD
Cyclopentolate—CHRM3—Signaling Pathways—HTR6—Alzheimer's disease	1.99e-05	0.000783	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ACHE—Alzheimer's disease	1.97e-05	0.000775	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CHAT—Alzheimer's disease	1.95e-05	0.000769	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—TPI1—Alzheimer's disease	1.95e-05	0.000769	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—INPP5D—Alzheimer's disease	1.94e-05	0.000766	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.94e-05	0.000766	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.94e-05	0.000764	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—GAB2—Alzheimer's disease	1.92e-05	0.000757	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—SST—Alzheimer's disease	1.92e-05	0.000757	CbGpPWpGaD
Cyclopentolate—BCHE—central nervous system—Alzheimer's disease	1.92e-05	0.041	CbGeAlD
Cyclopentolate—CHRM3—Signaling by GPCR—GAB2—Alzheimer's disease	1.91e-05	0.000754	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—SST—Alzheimer's disease	1.91e-05	0.000754	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of proteins—F2—Alzheimer's disease	1.89e-05	0.000743	CbGpPWpGaD
Cyclopentolate—BCHE—cerebellum—Alzheimer's disease	1.87e-05	0.0401	CbGeAlD
Cyclopentolate—CHRM1—Signaling by GPCR—APP—Alzheimer's disease	1.87e-05	0.000737	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—MAOB—Alzheimer's disease	1.87e-05	0.000737	CbGpPWpGaD
Cyclopentolate—CHRM3—brain—Alzheimer's disease	1.87e-05	0.0399	CbGeAlD
Cyclopentolate—CHRM3—Signaling by GPCR—APP—Alzheimer's disease	1.86e-05	0.000735	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—CCL2—Alzheimer's disease	1.84e-05	0.000727	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ENO1—Alzheimer's disease	1.84e-05	0.000726	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PTGS1—Alzheimer's disease	1.84e-05	0.000726	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—CCL2—Alzheimer's disease	1.84e-05	0.000724	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PSENEN—Alzheimer's disease	1.81e-05	0.000713	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CYP2D6—Alzheimer's disease	1.81e-05	0.000712	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PSENEN—Alzheimer's disease	1.8e-05	0.000711	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GAPDH—Alzheimer's disease	1.8e-05	0.000709	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APH1A—Alzheimer's disease	1.78e-05	0.000703	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APH1A—Alzheimer's disease	1.78e-05	0.000701	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PLCB1—Alzheimer's disease	1.77e-05	0.000696	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PLCB1—Alzheimer's disease	1.76e-05	0.000694	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—A2M—Alzheimer's disease	1.74e-05	0.000685	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NCSTN—Alzheimer's disease	1.74e-05	0.000685	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NCSTN—Alzheimer's disease	1.73e-05	0.000682	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of proteins—INS—Alzheimer's disease	1.71e-05	0.000673	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—LRP1—Alzheimer's disease	1.69e-05	0.000668	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—LRP1—Alzheimer's disease	1.69e-05	0.000666	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of proteins—CCL2—Alzheimer's disease	1.68e-05	0.000663	CbGpPWpGaD
Cyclopentolate—CHRM1—Circadian rythm related genes—TP53—Alzheimer's disease	1.67e-05	0.00066	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GAL—Alzheimer's disease	1.65e-05	0.000652	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GFAP—Alzheimer's disease	1.65e-05	0.000652	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of proteins—IGF1—Alzheimer's disease	1.65e-05	0.000651	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GAL—Alzheimer's disease	1.65e-05	0.00065	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GFAP—Alzheimer's disease	1.65e-05	0.00065	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PLCB1—Alzheimer's disease	1.62e-05	0.000637	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.59e-05	0.000625	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ABCA1—Alzheimer's disease	1.57e-05	0.000618	CbGpPWpGaD
Cyclopentolate—CHRM1—Circadian rythm related genes—IL6—Alzheimer's disease	1.53e-05	0.000604	CbGpPWpGaD
Cyclopentolate—BCHE—brain—Alzheimer's disease	1.52e-05	0.0326	CbGeAlD
Cyclopentolate—CHRM3—Metabolism—ACHE—Alzheimer's disease	1.51e-05	0.000596	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—INPP5D—Alzheimer's disease	1.49e-05	0.000589	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—A2M—Alzheimer's disease	1.46e-05	0.000575	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—A2M—Alzheimer's disease	1.45e-05	0.000573	CbGpPWpGaD
Cyclopentolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.45e-05	0.000572	CbGpPWpGaD
Cyclopentolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.45e-05	0.00057	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.44e-05	0.000567	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.43e-05	0.000565	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ENO1—Alzheimer's disease	1.42e-05	0.000559	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PTGS1—Alzheimer's disease	1.42e-05	0.000559	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PSEN2—Alzheimer's disease	1.41e-05	0.000557	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PSEN2—Alzheimer's disease	1.41e-05	0.000555	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CYP2D6—Alzheimer's disease	1.39e-05	0.000548	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—CCR5—Alzheimer's disease	1.36e-05	0.000537	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—CCR5—Alzheimer's disease	1.36e-05	0.000535	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PPARGC1A—Alzheimer's disease	1.35e-05	0.000532	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—HMOX1—Alzheimer's disease	1.34e-05	0.00053	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.33e-05	0.000525	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.33e-05	0.000524	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—BCHE—Alzheimer's disease	1.32e-05	0.000519	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PRKCG—Alzheimer's disease	1.31e-05	0.000515	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PRKCG—Alzheimer's disease	1.3e-05	0.000513	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NPY—Alzheimer's disease	1.3e-05	0.000512	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NPY—Alzheimer's disease	1.3e-05	0.000511	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IAPP—Alzheimer's disease	1.29e-05	0.000509	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IAPP—Alzheimer's disease	1.29e-05	0.000508	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CRH—Alzheimer's disease	1.25e-05	0.000494	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CRH—Alzheimer's disease	1.25e-05	0.000493	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PLCB1—Alzheimer's disease	1.24e-05	0.00049	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CCR5—Alzheimer's disease	1.24e-05	0.000488	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CCR5—Alzheimer's disease	1.23e-05	0.000486	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—LPL—Alzheimer's disease	1.23e-05	0.000485	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	1.21e-05	0.000477	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—HTR2A—Alzheimer's disease	1.21e-05	0.000476	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ABCA1—Alzheimer's disease	1.21e-05	0.000475	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NPS—Alzheimer's disease	1.19e-05	0.000469	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NPS—Alzheimer's disease	1.19e-05	0.000467	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.18e-05	0.000466	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PPP3CA—Alzheimer's disease	1.18e-05	0.000465	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—F2—Alzheimer's disease	1.17e-05	0.000461	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PTK2B—Alzheimer's disease	1.17e-05	0.000459	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—F2—Alzheimer's disease	1.17e-05	0.000459	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PTK2B—Alzheimer's disease	1.16e-05	0.000458	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GAB2—Alzheimer's disease	1.13e-05	0.000447	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NTRK2—Alzheimer's disease	1.13e-05	0.000447	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SST—Alzheimer's disease	1.13e-05	0.000447	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NTRK2—Alzheimer's disease	1.13e-05	0.000446	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GAB2—Alzheimer's disease	1.13e-05	0.000446	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SST—Alzheimer's disease	1.13e-05	0.000446	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CALM1—Alzheimer's disease	1.13e-05	0.000445	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CALM1—Alzheimer's disease	1.13e-05	0.000444	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GSK3A—Alzheimer's disease	1.12e-05	0.000443	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GSK3A—Alzheimer's disease	1.12e-05	0.000442	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—MTHFR—Alzheimer's disease	1.11e-05	0.000436	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APP—Alzheimer's disease	1.11e-05	0.000436	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APP—Alzheimer's disease	1.1e-05	0.000434	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—F2—Alzheimer's disease	1.06e-05	0.000418	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—F2—Alzheimer's disease	1.06e-05	0.000417	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PLCB1—Alzheimer's disease	1.04e-05	0.000411	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PLCB1—Alzheimer's disease	1.04e-05	0.00041	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PPARGC1A—Alzheimer's disease	1.04e-05	0.000409	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CALM1—Alzheimer's disease	1.03e-05	0.000408	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—HMOX1—Alzheimer's disease	1.03e-05	0.000407	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—APOE—Alzheimer's disease	1.03e-05	0.000406	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CAV1—Alzheimer's disease	1.02e-05	0.000403	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NGFR—Alzheimer's disease	9.73e-06	0.000383	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NGFR—Alzheimer's disease	9.7e-06	0.000382	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CREB1—Alzheimer's disease	9.67e-06	0.000381	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CREB1—Alzheimer's disease	9.64e-06	0.00038	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ADAM10—Alzheimer's disease	9.5e-06	0.000375	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ADAM10—Alzheimer's disease	9.47e-06	0.000373	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CCL2—Alzheimer's disease	9.46e-06	0.000373	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—LPL—Alzheimer's disease	9.46e-06	0.000373	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CCL2—Alzheimer's disease	9.43e-06	0.000372	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—S100B—Alzheimer's disease	8.99e-06	0.000354	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PPARG—Alzheimer's disease	8.98e-06	0.000354	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—S100B—Alzheimer's disease	8.96e-06	0.000353	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—INS—Alzheimer's disease	8.81e-06	0.000347	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IGF2—Alzheimer's disease	8.56e-06	0.000337	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IGF2—Alzheimer's disease	8.53e-06	0.000336	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—MTHFR—Alzheimer's disease	8.51e-06	0.000336	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IGF1R—Alzheimer's disease	8.27e-06	0.000326	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IGF1R—Alzheimer's disease	8.25e-06	0.000325	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CALM1—Alzheimer's disease	7.95e-06	0.000313	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—LPL—Alzheimer's disease	7.93e-06	0.000313	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—APOE—Alzheimer's disease	7.93e-06	0.000312	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—LPL—Alzheimer's disease	7.91e-06	0.000312	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MEF2C—Alzheimer's disease	7.86e-06	0.00031	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CAV1—Alzheimer's disease	7.85e-06	0.00031	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MEF2C—Alzheimer's disease	7.84e-06	0.000309	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—NOS3—Alzheimer's disease	7.72e-06	0.000304	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PRKCG—Alzheimer's disease	7.71e-06	0.000304	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PRKCG—Alzheimer's disease	7.69e-06	0.000303	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NGF—Alzheimer's disease	7.51e-06	0.000296	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NGF—Alzheimer's disease	7.49e-06	0.000295	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCR5—Alzheimer's disease	7.31e-06	0.000288	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCR5—Alzheimer's disease	7.28e-06	0.000287	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HTR2A—Alzheimer's disease	7.15e-06	0.000282	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HTR2A—Alzheimer's disease	7.13e-06	0.000281	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PTGS2—Alzheimer's disease	7.06e-06	0.000278	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PPARG—Alzheimer's disease	6.9e-06	0.000272	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—INS—Alzheimer's disease	6.77e-06	0.000267	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CALM1—Alzheimer's disease	6.67e-06	0.000263	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CALM1—Alzheimer's disease	6.65e-06	0.000262	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	6.65e-06	0.000262	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	6.65e-06	0.000262	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APOE—Alzheimer's disease	6.63e-06	0.000261	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—LEP—Alzheimer's disease	6.63e-06	0.000261	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	6.59e-06	0.00026	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CAV1—Alzheimer's disease	6.57e-06	0.000259	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	6.35e-06	0.00025	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ESR1—Alzheimer's disease	6.33e-06	0.000249	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—F2—Alzheimer's disease	6.27e-06	0.000247	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—F2—Alzheimer's disease	6.25e-06	0.000246	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	6.14e-06	0.000242	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NOTCH1—Alzheimer's disease	6.12e-06	0.000241	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—NOS3—Alzheimer's disease	5.94e-06	0.000234	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	5.76e-06	0.000227	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GSK3B—Alzheimer's disease	5.74e-06	0.000226	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	5.71e-06	0.000225	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	5.69e-06	0.000224	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—INS—Alzheimer's disease	5.68e-06	0.000224	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—INS—Alzheimer's disease	5.66e-06	0.000223	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	5.59e-06	0.00022	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	5.57e-06	0.00022	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	5.49e-06	0.000217	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	5.48e-06	0.000216	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PTGS2—Alzheimer's disease	5.43e-06	0.000214	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	4.98e-06	0.000196	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	4.97e-06	0.000196	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	4.27e-06	0.000168	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	4.25e-06	0.000168	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	4.23e-06	0.000167	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	4.22e-06	0.000166	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	4.2e-06	0.000166	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	4.19e-06	0.000165	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	3.89e-06	0.000153	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	3.88e-06	0.000153	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	3.87e-06	0.000153	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	3.86e-06	0.000152	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	3.59e-06	0.000141	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	3.58e-06	0.000141	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—AKT1—Alzheimer's disease	3.55e-06	0.00014	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	3.29e-06	0.00013	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	3.28e-06	0.000129	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—AKT1—Alzheimer's disease	2.73e-06	0.000108	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	2.71e-06	0.000107	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	2.7e-06	0.000107	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	2.48e-06	9.78e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	2.47e-06	9.75e-05	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	2.29e-06	9.02e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	2.28e-06	9e-05	CbGpPWpGaD
